The Antimonopoly Service has issued a ruling to collect 423 million soms from the company "Intelmed" (Bonetsky laboratory) into the republican budget. The decision was made due to violations of competition laws in the market for laboratory research services.
According to the analysis, "Intelmed", taking advantage of its dominant position during the COVID-19 pandemic, set monopolistically high prices for PCR testing services for coronavirus infection.